Preeminent Oncology Clinicians from Leading Cancer Centers Join Actinum’s Newly Established Iomab-B Scientific Advisory Board Jun 26, 2014
Actinium’s Actimab-A and Alpha-Particle Immunotherapy Platform Further Validated at Society for Nuclear Medicine Annual Meeting Jun 24, 2014
Actinium Set to Join Russell 3000®, Russell 2000®, Russell Global, and Russell Micro-Cap® Indexes Jun 17, 2014
Panelists at NewYorkBIO-CONference Highlight Prior Clinical Data Showing Iomab™-B Improves Survival and is Well-Tolerated Jun 11, 2014
Actinium KOL Joseph Jurcic, MD to Discuss the Role of Actinium’s Alpha-Particle Radiopharmaceuticals in the Treatment of Leukemia Patients at the 2014 Society of Nuclear Medicine and Molecular Imaging Annual Meeting Jun 5, 2014
Actinium Expands into Additional Offices in Metro Park in Edison, NJ to Support Growing Operations Jun 2, 2014
